Cargando…

Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020

BACKGROUND: Very few studies describe factors associated with COVID-19 diagnosis in children. AIM: We here describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 paediatric centres across Italy. METHODS: We included cases aged 0–18 years tested between 23 February...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzerini, Marzia, Sforzi, Idanna, Trapani, Sandra, Biban, Paolo, Silvagni, Davide, Villa, Giovanna, Tibaldi, Jessica, Bertacca, Luca, Felici, Enrico, Perricone, Giuseppina, Parrino, Roberta, Gioè, Claudia, Lega, Sara, Conte, Mariasole, Marchetti, Federico, Magista, Annamaria, Berlese, Paola, Martelossi, Stefano, Vaienti, Francesca, Valletta, Enrico, Mauro, Margherita, Dall’Amico, Roberto, Fasoli, Silvia, Gatto, Antonio, Chiaretti, Antonio, Dragovic, Danica, Pascolo, Paola, Pilotto, Chiara, Liguoro, Ilaria, Miorin, Elisabetta, Saretta, Francesca, Trobia, Gian Luca, Di Stefano, Antonella, Orlandi, Azzurra, Cardinale, Fabio, Lubrano, Riccardo, Testa, Alessia, Binotti, Marco, Moressa, Valentina, Barbi, Egidio, Armocida, Benedetta, Mariani, Ilaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034058/
https://www.ncbi.nlm.nih.gov/pubmed/33834960
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.14.2001248
_version_ 1783676473205325824
author Lazzerini, Marzia
Sforzi, Idanna
Trapani, Sandra
Biban, Paolo
Silvagni, Davide
Villa, Giovanna
Tibaldi, Jessica
Bertacca, Luca
Felici, Enrico
Perricone, Giuseppina
Parrino, Roberta
Gioè, Claudia
Lega, Sara
Conte, Mariasole
Marchetti, Federico
Magista, Annamaria
Berlese, Paola
Martelossi, Stefano
Vaienti, Francesca
Valletta, Enrico
Mauro, Margherita
Dall’Amico, Roberto
Fasoli, Silvia
Gatto, Antonio
Chiaretti, Antonio
Dragovic, Danica
Pascolo, Paola
Pilotto, Chiara
Liguoro, Ilaria
Miorin, Elisabetta
Saretta, Francesca
Trobia, Gian Luca
Di Stefano, Antonella
Orlandi, Azzurra
Cardinale, Fabio
Lubrano, Riccardo
Testa, Alessia
Binotti, Marco
Moressa, Valentina
Barbi, Egidio
Armocida, Benedetta
Mariani, Ilaria
author_facet Lazzerini, Marzia
Sforzi, Idanna
Trapani, Sandra
Biban, Paolo
Silvagni, Davide
Villa, Giovanna
Tibaldi, Jessica
Bertacca, Luca
Felici, Enrico
Perricone, Giuseppina
Parrino, Roberta
Gioè, Claudia
Lega, Sara
Conte, Mariasole
Marchetti, Federico
Magista, Annamaria
Berlese, Paola
Martelossi, Stefano
Vaienti, Francesca
Valletta, Enrico
Mauro, Margherita
Dall’Amico, Roberto
Fasoli, Silvia
Gatto, Antonio
Chiaretti, Antonio
Dragovic, Danica
Pascolo, Paola
Pilotto, Chiara
Liguoro, Ilaria
Miorin, Elisabetta
Saretta, Francesca
Trobia, Gian Luca
Di Stefano, Antonella
Orlandi, Azzurra
Cardinale, Fabio
Lubrano, Riccardo
Testa, Alessia
Binotti, Marco
Moressa, Valentina
Barbi, Egidio
Armocida, Benedetta
Mariani, Ilaria
author_sort Lazzerini, Marzia
collection PubMed
description BACKGROUND: Very few studies describe factors associated with COVID-19 diagnosis in children. AIM: We here describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 paediatric centres across Italy. METHODS: We included cases aged 0–18 years tested between 23 February and 24 May 2020. Our primary analysis focused on children tested because of symptoms/signs suggestive of COVID-19. RESULTS: Among 2,494 children tested, 2,148 (86.1%) had symptoms suggestive of COVID-19. Clinical presentation of confirmed COVID-19 cases included besides fever (82.4%) and respiratory signs or symptoms (60.4%) also gastrointestinal (18.2%), neurological (18.9%), cutaneous (3.8%) and other unspecific influenza-like presentations (17.8%). In multivariate analysis, factors significantly associated with SARS-CoV-2 positivity were: exposure history (adjusted odds ratio (AOR): 39.83; 95% confidence interval (CI): 17.52–90.55; p < 0.0001), cardiac disease (AOR: 3.10; 95% CI: 1.19–5.02; p < 0.0001), fever (AOR: 3.05%; 95% CI: 1.67–5.58; p = 0.0003) and anosmia/ageusia (AOR: 4.08; 95% CI: 1.69–9.84; p = 0.002). Among 190 (7.6%) children positive for SARS-CoV-2, only four (2.1%) required respiratory support and two (1.1%) were admitted to intensive care; all recovered. CONCLUSION: Recommendations for SARS-CoV-2 testing in children should consider the evidence of broader clinical features. Exposure history, fever and anosmia/ageusia are strong risk factors in children for positive SARS-CoV-2 testing, while other symptoms did not help discriminate positive from negative individuals. This study confirms that COVID-19 was a mild disease in the general paediatric population in Italy. Further studies are needed to understand risk, clinical spectrum and outcomes of COVID-19 in children with pre-existing conditions.
format Online
Article
Text
id pubmed-8034058
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-80340582021-04-12 Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 Lazzerini, Marzia Sforzi, Idanna Trapani, Sandra Biban, Paolo Silvagni, Davide Villa, Giovanna Tibaldi, Jessica Bertacca, Luca Felici, Enrico Perricone, Giuseppina Parrino, Roberta Gioè, Claudia Lega, Sara Conte, Mariasole Marchetti, Federico Magista, Annamaria Berlese, Paola Martelossi, Stefano Vaienti, Francesca Valletta, Enrico Mauro, Margherita Dall’Amico, Roberto Fasoli, Silvia Gatto, Antonio Chiaretti, Antonio Dragovic, Danica Pascolo, Paola Pilotto, Chiara Liguoro, Ilaria Miorin, Elisabetta Saretta, Francesca Trobia, Gian Luca Di Stefano, Antonella Orlandi, Azzurra Cardinale, Fabio Lubrano, Riccardo Testa, Alessia Binotti, Marco Moressa, Valentina Barbi, Egidio Armocida, Benedetta Mariani, Ilaria Euro Surveill Research BACKGROUND: Very few studies describe factors associated with COVID-19 diagnosis in children. AIM: We here describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 paediatric centres across Italy. METHODS: We included cases aged 0–18 years tested between 23 February and 24 May 2020. Our primary analysis focused on children tested because of symptoms/signs suggestive of COVID-19. RESULTS: Among 2,494 children tested, 2,148 (86.1%) had symptoms suggestive of COVID-19. Clinical presentation of confirmed COVID-19 cases included besides fever (82.4%) and respiratory signs or symptoms (60.4%) also gastrointestinal (18.2%), neurological (18.9%), cutaneous (3.8%) and other unspecific influenza-like presentations (17.8%). In multivariate analysis, factors significantly associated with SARS-CoV-2 positivity were: exposure history (adjusted odds ratio (AOR): 39.83; 95% confidence interval (CI): 17.52–90.55; p < 0.0001), cardiac disease (AOR: 3.10; 95% CI: 1.19–5.02; p < 0.0001), fever (AOR: 3.05%; 95% CI: 1.67–5.58; p = 0.0003) and anosmia/ageusia (AOR: 4.08; 95% CI: 1.69–9.84; p = 0.002). Among 190 (7.6%) children positive for SARS-CoV-2, only four (2.1%) required respiratory support and two (1.1%) were admitted to intensive care; all recovered. CONCLUSION: Recommendations for SARS-CoV-2 testing in children should consider the evidence of broader clinical features. Exposure history, fever and anosmia/ageusia are strong risk factors in children for positive SARS-CoV-2 testing, while other symptoms did not help discriminate positive from negative individuals. This study confirms that COVID-19 was a mild disease in the general paediatric population in Italy. Further studies are needed to understand risk, clinical spectrum and outcomes of COVID-19 in children with pre-existing conditions. European Centre for Disease Prevention and Control (ECDC) 2021-04-08 /pmc/articles/PMC8034058/ /pubmed/33834960 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.14.2001248 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Research
Lazzerini, Marzia
Sforzi, Idanna
Trapani, Sandra
Biban, Paolo
Silvagni, Davide
Villa, Giovanna
Tibaldi, Jessica
Bertacca, Luca
Felici, Enrico
Perricone, Giuseppina
Parrino, Roberta
Gioè, Claudia
Lega, Sara
Conte, Mariasole
Marchetti, Federico
Magista, Annamaria
Berlese, Paola
Martelossi, Stefano
Vaienti, Francesca
Valletta, Enrico
Mauro, Margherita
Dall’Amico, Roberto
Fasoli, Silvia
Gatto, Antonio
Chiaretti, Antonio
Dragovic, Danica
Pascolo, Paola
Pilotto, Chiara
Liguoro, Ilaria
Miorin, Elisabetta
Saretta, Francesca
Trobia, Gian Luca
Di Stefano, Antonella
Orlandi, Azzurra
Cardinale, Fabio
Lubrano, Riccardo
Testa, Alessia
Binotti, Marco
Moressa, Valentina
Barbi, Egidio
Armocida, Benedetta
Mariani, Ilaria
Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020
title Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020
title_full Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020
title_fullStr Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020
title_full_unstemmed Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020
title_short Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020
title_sort characteristics and risk factors for sars-cov-2 in children tested in the early phase of the pandemic: a cross-sectional study, italy, 23 february to 24 may 2020
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034058/
https://www.ncbi.nlm.nih.gov/pubmed/33834960
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.14.2001248
work_keys_str_mv AT lazzerinimarzia characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT sforziidanna characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT trapanisandra characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT bibanpaolo characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT silvagnidavide characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT villagiovanna characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT tibaldijessica characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT bertaccaluca characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT felicienrico characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT perriconegiuseppina characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT parrinoroberta characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT gioeclaudia characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT legasara characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT contemariasole characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT marchettifederico characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT magistaannamaria characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT berlesepaola characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT martelossistefano characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT vaientifrancesca characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT vallettaenrico characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT mauromargherita characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT dallamicoroberto characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT fasolisilvia characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT gattoantonio characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT chiarettiantonio characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT dragovicdanica characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT pascolopaola characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT pilottochiara characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT liguoroilaria characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT miorinelisabetta characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT sarettafrancesca characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT trobiagianluca characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT distefanoantonella characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT orlandiazzurra characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT cardinalefabio characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT lubranoriccardo characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT testaalessia characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT binottimarco characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT moressavalentina characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT barbiegidio characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT armocidabenedetta characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT marianiilaria characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020
AT characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020